Trexquant Investment’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Buy |
+48,821
| New | +$3.19M | 0.04% | 713 |
|
|
2024
Q3 | – | Sell |
-16,772
| Closed | -$1.07M | – | 1511 |
|
|
2024
Q2 | $1.07M | Sell |
16,772
-30,375
| -64% | -$1.93M | 0.02% | 980 |
|
|
2024
Q1 | $3.26M | Buy |
47,147
+18,663
| +66% | +$1.29M | 0.07% | 461 |
|
|
2023
Q4 | $1.57M | Sell |
28,484
-15,042
| -35% | -$829K | 0.04% | 644 |
|
|
2023
Q3 | $2.53M | Buy |
43,526
+5,607
| +15% | +$326K | 0.06% | 424 |
|
|
2023
Q2 | $2.04M | Buy |
37,919
+29,713
| +362% | +$1.6M | 0.05% | 486 |
|
|
2023
Q1 | $326K | Buy |
+8,206
| New | +$326K | 0.01% | 1170 |
|
|
2022
Q1 | – | Sell |
-10,199
| Closed | -$470K | – | 1325 |
|
|
2021
Q4 | $470K | Buy |
+10,199
| New | +$470K | 0.03% | 671 |
|
|
2021
Q1 | – | Sell |
-7,059
| Closed | -$205K | – | 1100 |
|
|
2020
Q4 | $205K | Buy |
+7,059
| New | +$205K | 0.02% | 878 |
|
|
2020
Q1 | – | Sell |
-4,213
| Closed | -$260K | – | 1078 |
|
|
2019
Q4 | $260K | Buy |
+4,213
| New | +$260K | 0.02% | 805 |
|
|
2018
Q2 | – | Sell |
-3,526
| Closed | -$205K | – | 881 |
|
|
2018
Q1 | $205K | Buy |
+3,526
| New | +$205K | 0.01% | 940 |
|
|
2015
Q4 | – | Sell |
-59,346
| Closed | -$2.34M | – | 990 |
|
|
2015
Q3 | $2.34M | Buy |
59,346
+48,946
| +471% | +$1.93M | 0.2% | 112 |
|
|
2015
Q2 | $645K | Buy |
10,400
+1,600
| +18% | +$99.2K | 0.07% | 514 |
|
|
2015
Q1 | $550K | Buy |
+8,800
| New | +$550K | 0.06% | 649 |
|